Harnessing medtech market alliances, ŌURA sets IPO plans in motion

ŌURA, creator of its namesake astute ring, has confidentially filed paperwork with the US Securities and Exchange Commission (SEC) for a projected archetypal nationalist offering (IPO) of its communal stock.

The fig of shares to beryllium offered and the terms scope for the projected offering person not yet been determined, the institution stated. Meanwhile, the circumstantial timing for the IPO was not specified, with ŌURA stating lone that it volition instrumentality spot aft the SEC “completes its reappraisal process, taxable to marketplace and different conditions.”

While Oura Ring is classified arsenic a user wellness merchandise for tracking wellness metrics, its exertion has intersected with the aesculapian instrumentality manufacture done assorted partnerships, notably successful the diabetes space.

Dexcom invested $75m successful ŌURA successful November 2024, forging a concern centred connected launching integrations to facilitate information travel betwixt Dexcom’s continuous glucose monitoring (CGM) products, including its glucose biosensors and apps, with ŌURA products. By integrating Dexcom’s CGM information with Oura ring’s wellness metrics specified arsenic sleep, stress, and cardiovascular data, the combined information is positioned to springiness users insights into aspects specified arsenic however mediocre slumber affects glucose variability and what meals origin glucose spikes.

Other companies that person partnered with ŌURA see Mira. The femtech institution announced a collaboration with the institution successful February 2026, allowing Oura astute ringing users to entree lab-grade hormone investigating data.

On 20 May, ŌURA announced that it was connected people to surpass 5 cardinal paid members this quarter, representing a ‘4x’ uptick implicit the past 2 years. The IPO plans travel a $900m Series E financing circular completed by the institution successful October 2025. The latest financing enactment ŌURA astatine an approximate valuation of $11bn.

At the clip of the Series E round, the institution revealed that it had achieved much than $500m successful 2024 revenue, doubling its maturation from the anterior year, and was connected people to treble gross again successful 2025, surpassing $1bn successful yearly sales. As of May 2026, the institution has not disclosed its 2025 net successful full.

"Harnessing medtech marketplace alliances, ŌURA sets IPO plans successful motion" was primitively created and published by Medical Device Network, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.